TRUE Private Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

TRUE Private Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,568	Closed	-$15K	–	647
2020 Q4	$15K	Hold	1,568	–	–	﹤0.01%	497
2020 Q3	$14K	Hold	1,568	–	–	﹤0.01%	455
2020 Q2	$19K	Hold	1,568	–	–	﹤0.01%	416
2020 Q1	$14K	Hold	1,568	–	–	﹤0.01%	408
2019 Q4	$15K	Buy	+1,568	New	+$14K	﹤0.01%	539
2019 Q3	–	Sell	-1,568	Closed	-$14K	–	659
2019 Q2	$14K	Buy	+1,568	New	+$18.9K	﹤0.01%	509
2018 Q4	–	Sell	-108	Closed	-$2.33K	–	842
2018 Q3	$2.33K	Buy	+108	New	+$2.51K	﹤0.01%	1008

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

TRUE Private Wealth Advisors's TEVA Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 1,568 shares — an estimated $15K sold.

TRUE Private Wealth Advisors first reported a position in TEVA in Q3 2018 and held it in 7 quarters. The position peaked at $19K in Q2 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

TRUE Private Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
TRUE Private Wealth Advisors sold 1,568 Teva Pharmaceuticals shares in Q1 2021, an estimated $15K.
TRUE Private Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 7 quarters.
TRUE Private Wealth Advisors's Teva Pharmaceuticals position peaked at $19K in Q2 2020.
451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.